Selection of patients with hepatocellular carcinoma for liver transplantation

British Journal of Surgery

Volumn 93, Issue 1, 2006, Pages 11-18

  Sutcliffe, R ^a   Maguire, D ^a   Portmann, B ^a   Rela, M ^a   Heaton, N ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CADAVER DONOR; CANCER GRADING; CANCER STAGING; HISTOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVING DONOR; MEDICAL ETHICS; MEDLINE; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; TUMOR BIOPSY; TUMOR RECURRENCE;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PATIENT SELECTION; PROGNOSIS; RISK FACTORS;

EID: 30944454843     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.5198     Document Type: Review

References (78)

1. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003; 139: 817-823.
2. Bain I, McMaster P. Benign and malignant liver tumours. Surgery 1997; 15: 169-174.
3. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699.
4. Margarit C, Charco R, Hidalgo E, Allende H, Castells L, Bilbao I. Liver transplantation for malignant diseases: selection and pattern of recurrence. World J Surg 2002; 26: 257-263.
5. Philosophe B, Greig PD, Hemming AW, Cattral MS, Wanless I, Rasul I et al. Surgical management of hepatocellular carcinoma: resection or transplantation? J Gastrointest Surg 1998; 2: 21-27.
6. Figueras J, Ibanez L, Ramos E, Jaurrieta E, Ortiz-de-Urbina J, Pardo F et al. Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study. Liver Transpl 2001; 7: 877-883.
7. Cillo U, Vitale A, Bassanello M, Boccagni P, Brolese A, Zanus G et al. Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg 2004; 239: 150-159.
8. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394-1403.
9. Hemming AW, Cattral MS, Reed AI, Van Der Werf WJ, Greig PD, Howard RJ. Liver transplantation for hepatocellular carcinoma. Ann Surg 2001; 233: 652-659.
10. Vivarelli M, Bellusci R, Cucchetti A, Cavrini G, De Ruvo N, Aden AA et al. Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosuppression? Transplantation 2002; 74: 1746-1751.
11. Gonzalez-Uriarte J, Valdivieso A, Gastaca M, Errasti G, Campo M, Hernandez MJ et al. Liver transplantation for hepatocellular carcinoma in cirrhotic patients. Transplant Proc 2001; 35: 1827-1829.
12. Nagasue N, Yukaya H, Hamada T, Hirose S, Kanashima R, Inokuchi K. The natural history of hepatocellular carcinoma. A study of 100 untreated cases. Cancer 1984; 54: 1461-1465.
13. Cottone M, Virdone R, Fusco G, Orlando A, Turri M, Caltagirone M et al. Asymptomatic hepatocellular carcinoma in Child's A cirrhosis: a comparison of natural history and surgical treatment. Gastroenterology 1989; 96: 1566-1571.
14. Tsai TJ, Chau GY, Lui WY, Tsay SH, King KL, Loong CC et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 2000; 127: 603-608.
15. Wiesner RH, Freeman RB, Mulligan DC. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology 2004; 127(Suppl 1): S261-S267.
16. Gondolesi G, Munoz L, Matsumoto C, Fishbein T, Sheiner P, Emre S et al. Hepatocellular carcinoma: a prime indication for living donor liver transplantation. J Gastrointest Surg 2002; 6: 102-107.
17. Olthoff KM, Rosove MH, Shackleton CR, Imagawa DK, Farmer DG, Northcross P et al. Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma. Ann Surg 1995; 221: 734-741.
18. Freise CE, Ferrell L, Liu T, Ascher NL, Roberts JP. Effect of systemic cyclosporine on tumor recurrence after liver transplantation in a model of hepatocellular carcinoma. Transplantation 1999; 67: 510-513.
19. Graziadei IW, Sandmueller H, Waldenberger P, Koenigsrainer A, Nachbaur K, Jaschke W et al. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 2003; 9: 557-563.
20. Cherqui D. Role of adjuvant treatment in liver transplantation for advanced hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 1998; 5: 35-40.
21. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-96.
22. Tamura S, Kato T, Berho M, Misiakos EP, O'Brien C, Reddy KR et al. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch Surg 2001; 136: 25-30.
23. Klintmalm GB. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg 1998; 228: 479-490.
24. Schlitt HJ, Neipp M, Weimann A, Oldhafer KJ, Schmoll E, Boeker K et al. Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol 1999; 17: 324-331.
25. Otto G, Heuschen U, Hofmann WJ, Krumm G, Hinz U, Herfarth C. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis. Ann Surg 1998; 227: 424-432.
26. De Carlis L, Giacomoni A, Pirotta V, Lauterio A, Slim AO, Bondinara GF et al. Treatment of HCC: the role of liver resection in the era of transplantation. Transplant Proc 2001; 33: 1453-1456.
27. Weimann A, Schlitt HJ, Oldhafer KJ, Hoberg S, Tusch G, Raab R. Is liver transplantation superior to resection in early stage hepatocellular carcinoma? Transplant Proc 1999; 31: 500-501.
28. Sasaki Y, Imaoka S, Kasugai H, Fujita M, Kawamoto S, Ishiguro S et al. A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge. Cancer 1987; 60: 1194-1203.
29. Yamamoto M, Arii S, Sugahara K, Tobe T. Adjuvant oral chemotherapy to prevent recurrence after curative resection for hepatocellular carcinoma. Br J Surg 1996; 83: 336-340.
30. Bruix J, Llovet JM, Castells A, Montana X, Bru C, Ayuso MC et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 1998; 27: 1578-1583.
31. Iwatsuki S, Dvorchik I, Marsh JW, Madariaga JR, Carr B, Fung JJ et al. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 2000; 191: 389-394.
32. Marsh JW, Casavilla A, Iwatsuki S, Dvorchik I, Subotin M, Balan V et al. Predicting the risk of tumor recurrence following transplantation for hepatocellular carcinoma. Hepatology 1997; 26: 1689-1691.
33. Regalia E, Fassati LR, Valente U, Pulvirenti A, Damilano I, Dardano G et al. Pattern and management of recurrent hepatocellular carcinoma after liver transplantation. J Hepatobiliary Pancreat Surg 1998; 5: 29-34.
34. Bechstein WO, Guckelberger O, Kling N, Rayes N, Tullius SG, Lobeck H et al. Recurrence-free survival after liver transplantation for small hepatocellular carcinoma. Transplint 1998; 11(Suppl 1): S189-S192.
35. Perez Saborido B, Loinaz Segurola C, Gimeno Calvo A, Meneu Diaz JC, Abradelo de Usera M, Calvo Pulido J et al. Liver transplantation for hepatocellular carcinoma: our experience from 1986. Transplant Proc 2003; 35: 1825-1826.
36. Jonas S, Bechstein WO, Steinmuller T, Herrmann M, Radke C, Berg T et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33: 1080-1086.
37. Schwartz M. Liver transplantation for hepatocellular carcinoma. Gastroentenlogy 2004; 127(Suppl 1): S268-S276.
38. Esnaola NF, Lauwers GY, Mirza NQ, Nagorney DM, Doherty D, Ikai I et al. Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg 2002; 6: 224-232.
39. Jourdan JL, Stubbs RS. Percutaneous biopsy of operable liver lesions: is it necessary or advisable? N Z Med J 1996; 109: 469-470.
40. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK et al. EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-430.
41. Torzilli G, Minagawa M, Takayama T, Inoue K, Hui AM, Kubota K et al. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 1999; 30: 889-893.
42. Durand F, Regimbeau JM, Belghiti J, Sauvanet A, Vilgrain V, Terris B et al. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol 2001; 35: 254-258.
43. Soresi M, Magliarisi C, Campagna P, Leto G, Bonfissuto G, Riili A et al. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. Anticancer Res 2003; 23: 1747-1753.
44. Smith EH. The hazards of fine-needle aspiration biopsy. Ultrasound Med Biol 1984; 10: 629-634.
45. Gupta S, Bent S, Kohlwes J. Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. Ann Intern Med 2003; 139: 46-50.
46. Burrel M, Llovet JM, Ayuso C, Iglesias C, Sala M, Miquel R et al. Barcelona Clinic Liver Cancer Group. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology 2003; 38: 1034-1042.
47. Cho CS, Knechtle SJ, Heisey DM, Hermina M, Armbrust M, D'Alessandro AM et al. Analysis of tumor characteristics and survival in liver transplant recipients with incidentally diagnosed hepatocellular carcinoma. J Gastrointest Surg 2001; 5: 5 94-601.
48. Stoker J, Romijn MG, de Man RA, Brouwer JT, Weverling GJ, van Muiswinkel JM et al. Prospective comparative study of spiral computer tomography and magnetic resonance imaging for detection of hepatocellular carcinoma. Gut 2002; 51: 105-107.
49. Kang BK, Lim JH, Kim SH, Choi D, Lim HK, Lee WJ et al. Preoperative depiction of hepatocellular carcinoma: ferumoxides-enhanced MR imaging versus triple-phase helical CT. Radiology 2003; 226: 79-85.
50. Hann LE, Winston CB, Brown KT, Akhurst T. Diagnostic imaging approaches and relationship to hepatobiliary cancer staging and therapy. Semin Surg Oncol 2000; 19: 94-115.
51. Montorsi M, Santambrogio R, Bianchi P, Opocher E, Cornalba GP, Dapri G et al. Laparoscopy with laparoscopic ultrasound for pretreatment staging of hepatocellular carcinoma: a prospective study. J Gastrointest Surg 2001; 5: 312-315.
52. Talwalkar JA, Gores GJ. Diagnosis and staging of hepatocellular carcinoma. Gastroenterology 2004; 127(Suppl 1):S126-S132.
53. Marsh JW, Finkelstein SD, Demetris AJ, Swalsky PA, Sasatomi E, Bandos A et al. Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival. Liver Transpl 2003; 9: 664-671.
54. Dumortier J, Lombard-Bohas C, Valette PJ, Boillot O, Scoazec JY, Berger F et al. Needle tract recurrence of hepatocellular carcinoma after liver transplantation. Gut 2000; 47: 301.
55. Fiore F, Daniele B, De Maio E, Tambaro R, Iaffaioli VR, Barbarisi A et al. Subcutaneous seeding of hepatocellular carcinoma after fine-needle percutaneous biopsy. J Clin Gastroenterol 2001; 33: 171.
56. Schotman SN, De Man RA, Stoker J, Zondervan PE, Ijzermans JN. Subcutaneous seeding of hepatocellular carcinoma after percutaneous needle biopsy. Gut 1999; 45: 626-627.
57. Sood A, Midha V, Sood N. Needle track metastasis of primary liver carcinoma after percutaneous needle aspiration. Am J Gastroenterol 2002; 97: 765-766.
58. Kim SH, Lim HK, Lee WJ, Cho JM, Jang HJ. Needle-tract implantation in hepatocellular carcinoma: frequency and CT findings after biopsy with a 19.5-gauge automated biopsy gun. Abdom Imaging 2000; 25: 246-250.
59. Ng KK, Poon RT, Lo CM, Liu CL, Lam CM, Ng IO et al. Impact of preoperative fine-needle aspiration cytologic examination on clinical outcome in patients with hepatocellular carcinoma in a tertiary referral center. Arch Surg 2004; 139: 193-200.
60. Navarro F, Taourel P, Michel J, Perney P, Fabre JM, Blanc F et al. Diaphragmatic and subcutaneous seeding of hepatocellular carcinoma following fine-needle aspiration biopsy. Liver 1998; 18: 251-254.
61. Arrivé L, Vurgait A, Monnier-Cholley L, Lewin M, Balladur P, Poupon R et al. Long-term follow-up after neoplastic seeding complicating percutaneous ethanol injection for treatment of hepatocellular carcinoma. Eur Radiol 2002; 12: 74-76.
62. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985; 56: 918-928.
63. Izumi R, Shimizu K, Iyobe T, Ii T, Yagi M, Matsui O et al. Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma. Hepatology 1994; 20: 295-301.
64. The Cancer of the Liver Italian Program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 1998; 28: 751-755.
65. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19: 329-338.
66. TNM American Joint Committee. Manual for Staging of Cancer (4th edn). JB Lippincott: Philadelphia, 1992; 89-91.
67. Farinati F, Rinaldi M, Gianni S, Naccarato R. How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system. Cancer 2000; 89: 2266-2273.
68. Cedrone A, Rapaccini GL, Pompili M, Grattagliano A, Aliotta A, Trombino C. Neoplastic seeding complicating percutaneous ethanol injection for treatment of hepatocellular carcinoma. Radiology 1992; 183: 787-788.
69. De Sio I, Castellano L, Calandra M, Romano M, Persico M, Del Vecchio-Blanco C. Ultrasound-guided fine needle aspiration biopsy of portal vein thrombosis in liver cirrhosis: results in 15 patients. J Gastroenterol Hepatol 1995; 10: 662-665.
70. Sorensen JB, Klee M, Palshof T, Hansen HH. Performance status assessment in cancer patients. An inter-observer variability study. Br J Cancer 1993; 67: 773-775.
71. Fernandez JA, Robles R, Marin C, Sanchez-Bueno F, Ramirez P, Pons JA et al. Can we expand the indications for liver transplantation among hepatocellular carcinoma patients with increased tumor size? Transplant Proc 2003; 35: 1818-1820.
72. Leung JY, Zhu AX, Gordon FD, Pratt DS, Mithoefer A, Garrigan K et al. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study. Liver Transpl 2004; 10: 1343-1354.
73. Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002; 8: 765-774.
74. Foxton MR, Portmann B, Muiesan P, Bowles M, Rela M, Heaton N et al. Survival after liver transplantation for hepatocellular carcinoma based on Milan, UCSF and extended criteria. Hepatology 2004; 40: S1, 547A.
75. UK Transplant, http://www.uktransplant.org.uk [February 2005].
76. Funaki NO, Tanaka J, Seto SI, Kasamatsu T, Kaido T, Imamura M. Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver. Hepatology 1997; 25: 564-568.
77. Muller C, Petermann D, Pfeffel F, Oestereicher C, Fugger R. Lack of specificity of albumin-mRNA-positive cells as a marker of circulating hepatoma cells. Hepatology 1997; 25: 896-899.
78. Kar S, Carr BI. Detection of liver cells in peripheral blood of patients with advanced-stage hepatocellular carcinoma. Hepatology 1995; 21: 403-407.